NCT03015038Completed
Study of the Immune Response in Colon Adenocarcinoma
Etude de la réponse Immunitaire Dans l'adénocarcinome Colique
Source: ClinicalTrials.gov · Last updated 10 Dec 2025
Brief summary (registry, in English)
Duration of each part of the study per patient: * Screening: From 1 to 4 weeks * Sampling period (blood and tissue): 1 day * Follow-up by patient: 60 months * Total study duration by patient: 84 months * Total inclusion duration: 24 months * Total Follow-up duration: 60 months * Total study duration: 84 months
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 12 Dec 2016
- Start date
- 5 Feb 2017
- Primary completion date
- 5 Feb 2024
- Lead sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Diseases
- Colorectal cancer
- NCT number
- NCT03015038
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 5 Feb 2017 to the primary completion date, 5 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with HIV seropositivity.
Other
- Patients under guardianship / curatorship
- Following Situations
- Persons unable to understand, read and / or sign an informed consent
- Patient with the following functions: investigator or co-investigator, research assistant, pharmacist, study coordinator or having any involvement in the study
- Uncooperative person or potentially non-compliant for the study and its procedures with predictable difficulties regular monitoring of over 1 year.
- No affiliation to a social security scheme, a universal medical coverage or any similar plan.
- Pregnant or lactating women.
- Rectal tumor location.
Who the study is looking for
- Patients aged 18 or more.
- Affiliation to a social security scheme
- Diagnosis of a colon adenocarcinoma.
- Patient have signed and dated consent of the study before undertaking procedures related to the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hopital Saint Louis Coordinator of this site? Confirm its status | Paris | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.